Trials / Recruiting
RecruitingNCT06345703
First-into-human Study of NS-136 in Healthy Subjects
A Phase 1, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and PK of Single and Multiple Ascending Oral Doses and Food Effect of NS-136 in Healthy Subjects
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- Sponsor
- NeuShen Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions. The main questions it aims to answer are: * Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen? * What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | NS-136 matching placebo |
| DRUG | NS-136 tablet | Investigational product NS-136 |
Timeline
- Start date
- 2024-04-30
- Primary completion
- 2024-11-01
- Completion
- 2025-02-01
- First posted
- 2024-04-03
- Last updated
- 2024-11-19
Locations
2 sites across 2 countries: Australia, China
Source: ClinicalTrials.gov record NCT06345703. Inclusion in this directory is not an endorsement.